Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Other Non-Current Assets (2016 - 2026)

OptimizeRx's Other Non-Current Assets history spans 15 years, with the latest figure at $112.1 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 4.23% to $112.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $112.1 million, a 4.23% decrease, with the full-year FY2025 number at $112.1 million, down 4.23% from a year prior.
  • Other Non-Current Assets hit $112.1 million in Q4 2025 for OptimizeRx, down from $113.9 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for OPRX hit a ceiling of $117.0 million in Q4 2024 and a floor of $362000.0 in Q3 2024.
  • Historically, Other Non-Current Assets has averaged $51.3 million across 5 years, with a median of $36.0 million in 2022.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 99.01% in 2024 and later surged 31359.12% in 2025.
  • Tracing OPRX's Other Non-Current Assets over 5 years: stood at $25.7 million in 2021, then soared by 39.68% to $35.9 million in 2022, then tumbled by 98.42% to $568000.0 in 2023, then skyrocketed by 20506.87% to $117.0 million in 2024, then fell by 4.23% to $112.1 million in 2025.
  • Business Quant data shows Other Non-Current Assets for OPRX at $112.1 million in Q4 2025, $113.9 million in Q3 2025, and $115.1 million in Q2 2025.